Popular Articles

For Its Palliative And End-Of-Life Efforts OHSU Wins National Award
Oregon Health & Science University has been named a Circle of Life Award winner for its innovative program that improves the care of patients near the end of life or with life-threatening conditions.
new payday loan lenders Payday loan advance - loans till payday with bad credit history.
Medical Defence Union's New Scottish Recruits Help Meet Doctors' Demands For Medico-Legal Advice, UK
The Medical Defence Union (MDU) has recruited three new medico-legal advisers in Scotland, bringing its team of experts north of the border to nine - its biggest ever team in the country.
News of the day
Important Therapeutic Target For Breast Cancer: Newly Appreciated Membrane Estrogen Receptor
New research at Rhode Island Hospital has uncovered the biological effects of a novel membrane estrogen receptor, a finding that has potential implications for hormonal therapy for breast cancer. The study is published in the July edition of the journal Molecular Endocrinology. This new study by Edward Filardo, MD, and his research team further supports earlier published work by the group that linked the transmembrane receptor, GPR30/GPER-1, to specific estrogen binding, rapid estrogen signaling and breast cancer metastasis. "What is exciting about this new work," says Filardo, "is that it provides some insight into the influence of GPR30 at the cellular level. It shows that estrogen action through GPR30 allows for breast tumor cell survival, and not breast tumor cell proliferation." Prior studies by Filardo"s group showed that estrogen acts through GPR30 to promote the rapid release of preformed growth factors that are tethered to the surface of breast cancer cells. Their latest study was conducted in an effort to better understand the mechanism by which GPR30 triggered the release of epidermal growth factor (EGF) polypeptides from the surface of breast cancer cells.
Cardiovascular

$13.4 Million NIH Grant Received By Pitt To Create Virtual Models For Swine Flu, Epidemics

As the world prepares for a probable resurgence of H1N1 in the coming months, University of Pittsburgh researchers are controlling the spread of infectious diseases virtually with a $13.4 million National Institutes of Health (NIH) grant to establish a Center of Excellence in Modeling of Infectious Diseases. The five-year grant, part of the NIH"s Modeling of Infectious Disease Agent Study (MIDAS) program, funds the development and testing of computer simulations that will ultimately enable public health officials and policymakers to evaluate intervention strategies to contain infectious disease outbreaks. The center, led by Donald S. Burke, M.D., dean of the University of Pittsburgh Graduate School of Public Health, uses census and other data sets to build simulations of individuals as they move about and interact with one another through schools, workplaces, households and communities. By modeling their contacts, the Pitt team is working to determine the likelihood a person will spread the disease to others, and to evaluate which interventions might be the most effective such as school closings, travel restrictions, hand washing, vaccines or a combination of these techniques. "Stopping the spread of infectious diseases remains one of the most significant public health challenges of our time," Dr. Burke said. "It is difficult to predict how infectious disease control strategies will work because the spread of infection through a population depends on a multitude of factors. But by testing interventions "in silico" before an epidemic occurs, we can work through which strategies will be the most likely to succeed in preventing illness and death." "The MIDAS center at the University of Pittsburgh brings together an exceptionally talented group of investigators," said Irene Eckstrand, Ph.D., who co-directs the MIDAS program at the National Institute of General Medical Sciences, part of the NIH. "Their diverse areas of expertise will be a huge asset in building robust models that provide timely and practical information that public health policymakers need. The center also will serve as a hub for training the next generation of infectious disease modelers." Projects funded by the grant include: developing statistical tools to define the features of a pathogen and its spread through a population; identifying personal health behaviors and the social factors that influence decision-making related to prevention; tracking the evolution of infectious diseases over time; studying the impact of the seasons and variations in climate on infectious disease trajectories; putting a system in place to effectively implement an intervention; and providing new computational tools to local health officials. These projects build on large-scale simulations previously developed by Dr. Burke and his colleagues to control a threatening avian influenza pandemic. These models were influential in forming the World Health Organization"s decision about the size of antiviral medicine stockpiles needed to quash a possible avian flu outbreak, and in shaping U.S. Department of Health and Human Services" policies about the impact of "social distancing" during an influenza epidemic. Launched in 2004, MIDAS is a collaborative network of research scientists who use computational, statistical and mathematical models to understand infectious disease dynamics. The network focuses on emerging infectious diseases that may occur naturally or deliberately. The University of Pittsburgh Graduate School of Public Health (GSPH), founded in 1948 and now one of the top-ranked schools of public health in the United States, conducts research on public health and medical care that improves the lives of millions of people around the world. GSPH is a leader in devising new methods to prevent and treat cardiovascular diseases, HIV/AIDS, cancer and other important public health problems. Clare Collins University of Pittsburgh Schools of the Health Sciences


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):